Innoviva, Inc. (INVA)
21.02
0.00 (0.00%)
USD |
NASDAQ |
Aug 25, 10:46
Innoviva Debt to Equity Ratio : 0.2187 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2187 |
| March 31, 2026 | 0.2435 |
| December 31, 2025 | 0.2294 |
| September 30, 2025 | 0.2564 |
| June 30, 2025 | 0.7237 |
| March 31, 2025 | 0.6976 |
| December 31, 2024 | 0.6527 |
| September 30, 2024 | 0.6745 |
| June 30, 2024 | 0.6772 |
| March 31, 2024 | 0.6385 |
| December 31, 2023 | 0.6653 |
| September 30, 2023 | 0.8271 |
| June 30, 2023 | 0.9344 |
| March 31, 2023 | 0.798 |
| December 31, 2022 | 1.086 |
| September 30, 2022 | 0.9657 |
| June 30, 2022 | 1.398 |
| March 31, 2022 | 1.402 |
| December 31, 2021 | 0.9516 |
| September 30, 2021 | 0.9739 |
| June 30, 2021 | 1.183 |
| March 31, 2021 | 0.6111 |
| December 31, 2020 | 0.714 |
| September 30, 2020 | 0.7895 |
| June 30, 2020 | 0.8344 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.999 |
| December 31, 2019 | 1.203 |
| September 30, 2019 | 1.456 |
| June 30, 2019 | 1.712 |
| March 31, 2019 | 2.052 |
| December 31, 2018 | 2.496 |
| September 30, 2018 | -3.421 |
| June 30, 2018 | -3.092 |
| March 31, 2018 | -2.269 |
| December 31, 2017 | -2.468 |
| September 30, 2017 | -2.706 |
| June 30, 2017 | -2.204 |
| March 31, 2017 | -2.122 |
| December 31, 2016 | -2.029 |
| September 30, 2016 | -1.965 |
| June 30, 2016 | -1.998 |
| March 31, 2016 | -2.029 |
| December 31, 2015 | -2.184 |
| September 30, 2015 | -2.304 |
| June 30, 2015 | -2.512 |
| March 31, 2015 | -2.814 |
| December 31, 2014 | -3.249 |
| September 30, 2014 | -3.651 |
| June 30, 2014 | -3.933 |
| March 31, 2014 | 1.092 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Zevra Therapeutics, Inc. | 0.0069 |
| Collegium Pharmaceutical, Inc. | 3.905 |
| CorMedix, Inc. | 0.315 |
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.703B |
| Total Liabilities (Quarterly) | 469.46M |
| Shareholders Equity (Quarterly) | 1.233B |
| Current Ratio | 16.01 |
| Net Debt Paydown Yield | 2.20% |